Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Bulimia Nervosa Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

16 recruiting trials for Bulimia Nervosa. Eligibility criteria explained in plain English.

TrialFinderData lists 16 Bulimia Nervosa clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Early Phase 1 is the largest group at 50% (1 studies); the largest phase groups are Early Phase 1: 1, Phase 1: 1.

Research is led by Icahn School of Medicine at Mount Sinai (3), University of California, San Diego (2), University of Texas Southwestern Medical Center (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Educational (behavioral, 1 trial), followed by Interactive, ED-MINERVA Program.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
16
Total Trials
16
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Track Bulimia Nervosa trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06198023

Targeting Social Function in Anxiety and Eating Disorders

Social processing and cognition are often altered in patients with eating disorders. The goal of this clinical trial is to assess two different social therapeutic interventions --...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 601 location
RECRUITINGNCT07212075

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Mental conditions and disorders (e.g. distress, depressive, anxiety, and eating disorders) are more prevalent in people with diabetes (PWD) and associated with reduced quality of...

Sponsor: Forschungsinstitut der Diabetes Akademie MergentheimEnrolling: 18093 locations
RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGNCT06431854

Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program

The aim of this study is to investigate the efficacy, efficiency, and patient experience of a new intervention program on adolescents with high-complexity eating disorders (ED). A...

Sponsor: Fundació Sant Joan de DéuEnrolling: 1201 location
RECRUITINGNCT05304104

Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans

When untreated, eating disorders present with tremendous burdens to affected active duty Service members and Veterans and their families, and are very costly to the DoD and VA...

Sponsor: VA Connecticut Healthcare SystemEnrolling: 1441 location
RECRUITINGEarly Phase 1NCT05509257

Naltrexone Neuroimaging in Teens With Eating Disorders

Using a randomized, placebo-controlled, crossover study, this study will evaluate functional magnetic resonance imaging (fMRI) as a pharmacodynamic biomarker of opioid antagonism...

Sponsor: Children's Mercy Hospital Kansas CityEnrolling: 601 location
RECRUITINGNCT05879679

Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating...

Craving is defined as an irrepressible urge to consume certain products and represents one of the key factors in severe substance use disorders, as illustrated by its recent...

Sponsor: Laval UniversityEnrolling: 603 locations
RECRUITINGNCT05812950

Clinical and Cost-effectiveness of Group Schema Therapy for Complex Eating Disorders: the GST-EAT Study

Amongst psychiatric illnesses, eating disorders (EDs) are notoriously difficult to treat and have a high mortality rate. The average duration of an ED is 6 years and for a...

Sponsor: Maastricht UniversityEnrolling: 2307 locations
RECRUITINGPhase 1NCT07542145

MDMA Assisted Therapy for BN

This project will evaluate MDMA Assisted Therapy (MDMA-AT) assisted psychotherapy for the treatment of Bulimia Nervosa (BN) over a 10-week period. Preliminary data suggests that...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 401 location
RECRUITINGNCT05995496

Changes in Inhibition and Valuation After Eating

An impaired ability to exert control has been implicated in bulimia nervosa (BN), but this impairment may not represent a stable trait or be the most effective focus for...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 1501 location
RECRUITINGNCT05614024

Neurofeedback During Eating for Bulimia Nervosa

The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable brain...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 301 location
RECRUITINGNCT05056597

Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa

The purpose of this study is to investigate areas of the brain responsible for 'liking', 'wanting', and learning in adults with eating disorders using brain imaging techniques,...

Sponsor: University of California, San DiegoEnrolling: 2521 location
RECRUITINGNCT06566612

Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa

The purpose of this study is to investigate areas of the brain responsible for avoidance learning in adults with eating disorders using brain imaging techniques, computer tasks,...

Sponsor: University of California, San DiegoEnrolling: 781 location
RECRUITINGNCT06799962

AI and VR Devices for Eating Behavior Rehabilitation

Eating disorders (ED) affect the relationship with food and body image. Virtual reality (VR), combined with artificial intelligence (AI), offers new clinical solutions, overcoming...

Sponsor: Istituto per la Ricerca e l'Innovazione BiomedicaEnrolling: 801 location
RECRUITINGNCT04917068

Neurobiological and Psychological Maintenance Mechanisms Associated With Anticipatory Reward in Bulimia Nervosa

The purpose of this investigation is to identify the potentially crucial role of anticipatory reward mechanisms maintaining bulimic behavior (i.e., binge eating and purging) in...

Sponsor: University of MinnesotaEnrolling: 1001 location
RECRUITINGNCT06874348

Functional MRI During Resting State in Patients with Eating Disorders

The goal of this observational study is to learn if clinical and neurophysiological characteristics dynamics may follow similar trends in a longitudinal characterization of...

Sponsor: Meyer Children's Hospital IRCCSEnrolling: 502 locations

Frequently Asked Questions

There are currently 16 clinical trials for Bulimia Nervosa, with 16 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Bulimia Nervosa, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Bulimia Nervosa, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.